Key result
The time to peak values, time of total release, and half-lives of cardiac enzymes in acute myocardial infarction follow the sequential order of MYO < CK-MB < CK < ASAT < LD1 < LD.
Observational (n=47)
No
Answers are grounded in this paper and cite their sources.
Cardiac enzymes exhibit distinct release kinetics and half-lives following myocardial infarction, with fast markers (CK-MB, MYO) better suited for tracking rapid changes and slow markers (LD1) potentially better for estimating infarct size.
Release characteristics of S-LD, S-LD1, S-ASAT, S-CK and S-CK-MB were studied in 47 consecutive AMI patients. In addition, previously obtained data for serum myoglobin (S-MYO) were compared. Serum was sampled at regular intervals after admission to the Coronary Care Unit (CCU). The release rate and half lives of the enzymes were calculated according to a one-compartment kinetic model. The time to peak values, the time of total release and the half lives were interrelated in the following order: MYO less than CK-MB less than CK less than ASAT less than LD1 less than LD which coincides with the wellknown appearance and disappearance rates in serum. The ratio between mean peak values and upper reference limits followed the reverse order. The finding that the release rate of enzymes and half-lives co-vary is hypothetically suggested to be attributed to differences in rate of membrane diffusion. There is indirect evidence that a slow indicator such as LD1 reflects infarct size better than fast indicators with rapid release and removal such as MYO or CK-MB. However, these fast markers have a better signal to noise ratio, whereby they probably reflect changes in the infarction process better.
No takes yet. Share an insight, caveat, or question.
Sylvén et al. (1987) conducted an observational in Acute Myocardial Infarction (n=47). Cardiac enzyme markers (MYO, CK-MB, CK, ASAT, LD1, LD) was evaluated on Enzyme release characteristics (time to peak, time to maximal rate of release, and half-lives). The time to peak values, time of total release, and half-lives of cardiac enzymes in acute myocardial infarction follow the sequential order of MYO < CK-MB < CK < ASAT < LD1 < LD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: